Blended inpatient psychiatry depression care - a randomized controlled pilot study

Blended inpatient psychiatry depression care - a randomized controlled pilot study - POT-ICD

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00027575

Enrollment

Registered

2022-01-13

Start date

2022-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F33

Interventions

Group 1: Intervention group: Blended therapy condition consisting of a weekly psychotherapeutic session (at least 20min) on site, as well as a weekly scheduled online module (duration: 30-60 min) as w

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria for patients: - sufficient german language skills - written informed consent - inpatient at BKH Günzburg - age >=18 - main diagnosis: F32/F33 - no contraindications (based on therapist assessment) - perspective of at least 5 weeks inpatient treatment (based on therapist assessment) Inclusion criteria for therapists: - sufficient german language skills - written informed consent - working in inpatient setting as psychologist, psychotherapist in training (either psychologist or medical) or licensed psychotherapist (either psychologist or medical) - conduct of psychotherapeutic sessions in the inpatient setting

Exclusion criteria

Exclusion criteria: no further exclusion criteria

Design outcomes

Primary

Measure	Time frame
Feasibility: There are two measurement points (T0: prior to randomization; T1: 5 weeks after randomization): - Adherence (participation in psychotherapeutic sessions and number of completed online-modules, T1) - Acceptance (Attitudes Toward Technology, ATT; T0, T1 only in intervention group) - Satisfaction (ZUF-8, T1)	—

Secondary

Measure	Time frame
All questionnaires are self-report questionnaires. Measurement points are: T0 - prior to randomization, T1 - 5 weeks post-randomization: - Depressive symptom severity (QIDS-SR16, T0, T1) - Anxiety (GAD-7, T0, T1) - Quality of Life (AQoL-6D, T0, T1) - Self-Management (SMST, T0, T1) - Mental Health Self Efficacy (MHSES, T0, T1) - Therapeutic Alliance (WAI-SR, T1)	—

Countries

Germany

Contacts

Public ContactLina Braun

Abt. für Klinische Psychologie und PsychotherapieUniversität Ulm

lina.braun@uni-ulm.de+49-(0)731/50 32814

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026